What is Genetics Associates?
Headquartered in Nashville, Tennessee, Genetics Associates operates as a critical infrastructure provider for the medical community, delivering high-precision clinical cytogenetic and molecular diagnostic services. By serving a diverse clientele that includes private practitioners, hospitals, and diagnostic laboratories, the company has established a reputation for operational excellence and rapid turnaround times. The organization maintains rigorous quality standards, holding accreditation from the College of American Pathology and certification under the Clinical Laboratory Improvement Amendments. Beyond its diagnostic capabilities, the firm serves as an educational hub, fostering the next generation of cytogenetic technologists through specialized training programs.
How much funding has Genetics Associates raised?
Genetics Associates has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Genetics Associates
PPP
Public-Private Partnership
What's next for Genetics Associates?
The infusion of capital is expected to catalyze the next phase of the company's growth strategy, likely focusing on the scaling of laboratory operations and the integration of advanced molecular diagnostic technologies. As the firm transitions through this late-stage financing cycle, management will likely prioritize the expansion of its service reach across the United States. By leveraging this investment, Genetics Associates aims to solidify its market position, enhance its diagnostic throughput, and continue its commitment to clinical accuracy in an increasingly complex genomic medicine environment. The strategic deployment of these funds will be instrumental in maintaining the firm's competitive edge in the diagnostic services sector.
See full Genetics Associates company page
